Nadler Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
2,120
+100
+5% +$13.2K 0.02% 120
2026
Q1
$282K Sell
2,020
-2
-0.1% -$280 0.03% 112
2025
Q4
$248K Buy
2,022
+12
+0.6% +$1.46K 0.02% 118
2025
Q3
$223K Hold
2,010
0.02% 126
2025
Q2
$223K Hold
2,010
0.02% 123
2025
Q1
$225K Buy
+2,010
New +$207K 0.02% 113
2023
Q2
Sell
-2,640
Closed -$219K 118
2023
Q1
$219K Hold
2,640
0.03% 104
2022
Q4
$227K Buy
+2,640
New +$209K 0.04% 99
2022
Q1
Sell
-3,147
Closed -$229K 129
2021
Q4
$229K Hold
3,147
0.03% 118
2021
Q3
$220K Hold
3,147
0.04% 115
2021
Q2
$217K Buy
+3,147
New +$210K 0.04% 123
2020
Q3
Sell
-2,692
Closed -$207K 102
2020
Q2
$207K Buy
+2,692
New +$206K 0.05% 95
2016
Q4
Sell
-2,804
Closed -$222K 84
2016
Q3
$222K Sell
2,804
-1,031
-27% -$83.8K 0.09% 73
2016
Q2
$320K Sell
3,835
-42
-1% -$3.73K 0.14% 59
2016
Q1
$356K Buy
3,877
+211
+6% +$19K 0.16% 53
2015
Q4
$371K Buy
3,666
+19
+0.5% +$1.98K 0.17% 51
2015
Q3
$358K Buy
3,647
+696
+24% +$77.3K 0.18% 53
2015
Q2
$345K Sell
2,951
-154
-5% -$16.8K 0.16% 54
2015
Q1
$305K Buy
3,105
+405
+15% +$41.1K 0.15% 60
2014
Q4
$255K Buy
2,700
+590
+28% +$61K 0.13% 68
2014
Q3
$225K Buy
+2,110
New +$207K 0.13% 70

Other funds holding GILD

Nadler Financial Group's GILD Position: Q2 2026 in Review

Nadler Financial Group increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $13.2K and bringing the position to 2,120 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #120.

Nadler Financial Group first reported a position in GILD in Q3 2014 and has held it in 21 quarters since. The position peaked at $371K in Q4 2015. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nadler Financial Group held 2,120 shares of Gilead Sciences worth $268K as of Q2 2026.
  • Nadler Financial Group bought 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
  • Gilead Sciences made up 0.02% of Nadler Financial Group's portfolio in Q2 2026, its #120 holding.
  • Nadler Financial Group first reported a position in Gilead Sciences in Q3 2014 and has held it in 21 quarters since.
  • Nadler Financial Group's Gilead Sciences position peaked at $371K in Q4 2015.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.